Paper40366385
Effects of SGLT2 inhibitors on ion channels in heart failure: focus on the endothelium.
Wang M and 3 others. Basic Res Cardiol, 2025. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Effects of SGLT2 inhibitors on ion channels in heart failure: focus on the endothelium. Papers, record 40366385. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40366385
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Sodium-Glucose Transporter 2 Inhibitors | Major topic |
| Heart Failure | Major topic |
| Endothelium, Vascular | Major topic |
| Ion Channels | Major topic |
| Endothelial Cells | Major topic |
| Humans | |
| Animals |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 202208130005 | Chinese Government Scholarship | PubMed | ||
| 4458 | Amsterdams Universiteitsfonds | PubMed |
Source PubMed
References189
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11698234 | Micromolar Ca(2+) from sparks activates Ca(2+)-sensitive K(+) channels in rat cerebral artery smooth muscle. | Am J Physiol Cell Physiol | 2001 | https://conductscience.org/library/papers/11698234 | PubMed |
| 2 | 34649282 | Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. | Eur Heart J | 2021 | https://conductscience.org/library/papers/34649282 | PubMed |
| 3 | 31500313 | Vascular Endothelial Cell Biology: An Update. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31500313 | PubMed |
| 4 | 39571673 | Empagliflozin prevents TNF-α induced endothelial dysfunction under flow -the potential involvement of calcium and sodium-hydrogen exchanger. | Eur J Pharmacol | 2025 | https://conductscience.org/library/papers/39571673 | PubMed |
| 5 | 38520086 | Heart failure care in the Central and Eastern Europe and Baltic region: status, barriers, and routes to improvement. | ESC Heart Fail | 2024 | https://conductscience.org/library/papers/38520086 | PubMed |
| 6 | 32008372 | Local Peroxynitrite Impairs Endothelial Transient Receptor Potential Vanilloid 4 Channels and Elevates Blood Pressure in Obesity. | Circulation | 2020 | https://conductscience.org/library/papers/32008372 | PubMed |
| 7 | 38928371 | Hypertension and Heart Failure: From Pathophysiology to Treatment. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38928371 | PubMed |
| 8 | 16467502 | Role of potassium in regulating blood flow and blood pressure. | Am J Physiol Regul Integr Comp Physiol | 2006 | https://conductscience.org/library/papers/16467502 | PubMed |
| 9 | 38118414 | Dapagliflozin protects against chronic heart failure in mice by inhibiting macrophage-mediated inflammation, independent of SGLT2. | Cell Rep Med | 2023 | https://conductscience.org/library/papers/38118414 | PubMed |
| 10 | 38061206 | Empagliflozin prevents oxidative stress in human coronary artery endothelial cells via the NHE/PKC/NOX axis. | Redox Biol | 2024 | https://conductscience.org/library/papers/38061206 | PubMed |
| 11 | 26724178 | Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. | Lancet | 2016 | https://conductscience.org/library/papers/26724178 | PubMed |
| 12 | 39922424 | Sodium-glucose cotransporter 2 inhibitor empagliflozin enhances autophagy and reverses remodeling in hearts with large, old myocardial infarctions. | Eur J Pharmacol | 2025 | https://conductscience.org/library/papers/39922424 | PubMed |
| 13 | 35363499 | 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. | Circulation | 2022 | https://conductscience.org/library/papers/35363499 | PubMed |
| 14 | 12482889 | Freshly isolated bovine coronary endothelial cells do not express the BK Ca channel gene. | J Physiol | 2002 | https://conductscience.org/library/papers/12482889 | PubMed |
| 15 | 27872234 | Downregulation of Endothelial Transient Receptor Potential Vanilloid Type 4 Channel and Small-Conductance of Ca2+-Activated K+ Channels Underpins Impaired Endothelium-Dependent Hyperpolarization in Hypertension. | Hypertension | 2017 | https://conductscience.org/library/papers/27872234 | PubMed |
| 16 | 39739876 | SGLT2 expression in human vasculature and heart correlates with low-grade inflammation and causes eNOS-NO/ROS imbalance. | Cardiovasc Res | 2025 | https://conductscience.org/library/papers/39739876 | PubMed |
| 17 | 11356638 | NHE and ICAM-1 expression in hypoxic/reoxygenated coronary microvascular endothelial cells. | Am J Physiol Heart Circ Physiol | 2001 | https://conductscience.org/library/papers/11356638 | PubMed |
| 18 | 37504285 | The Role of the Piezo1 Mechanosensitive Channel in Heart Failure. | Curr Issues Mol Biol | 2023 | https://conductscience.org/library/papers/37504285 | PubMed |
| 19 | 30194266 | Piezo1 and Gq/G11 promote endothelial inflammation depending on flow pattern and integrin activation. | J Exp Med | 2018 | https://conductscience.org/library/papers/30194266 | PubMed |
| 20 | 25488697 | Pharmacodynamics, efficacy and safety of sodium-glucose co-transporter type 2 (SGLT2) inhibitors for the treatment of type 2 diabetes mellitus. | Drugs | 2015 | https://conductscience.org/library/papers/25488697 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42978803 | Complex antiarrhythmic effects of empagliflozin in non-ischemic HFrEF cardiomyocytes. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42978803 | PubMed |
| 42368857 | Molecular Interplay between hypertension and dyslipidemia in cardiovascular pathogenesis: toward precision-based therapeutic strategies. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42368857 | PubMed |
| 42318351 | Empagliflozin-pirfenidone dual therapy improves cardiac function and structure in a preclinical two-hit HFpEF model. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42318351 | PubMed |
| 42168622 | Empagliflozin restores cardiac function in obese-diabetic HFpEF mice but further alters gene expression. | Basic Res Cardiol | 2026 | https://conductscience.org/library/papers/42168622 | PubMed |
| 42148365 | GBVAM as a Novel NHE1 Inhibitor Alleviates Doxorubicin-Induced Cardiotoxicity via PI3K/Akt/mTOR Pathway. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/42148365 | PubMed |
| 42110178 | Mechanisms and Therapeutic Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure. | Rev Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42110178 | PubMed |
| 41995817 | Empagliflozin improves metabolism and prevents myocardial and coronary dysfunction in streptozotocin-diabetic and non-diabetic rats subjected to ischemia/reperfusion. | Basic Res Cardiol | 2026 | https://conductscience.org/library/papers/41995817 | PubMed |
| 41487902 | SGLT2 inhibitors in hemodialysis or peritoneal dialysis patients: rationale and state-of-the art. | Clin Kidney J | 2026 | https://conductscience.org/library/papers/41487902 | PubMed |
| 41393541 | Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors in Atrial Fibrillation: Clinical Implications, Mechanisms, and Therapeutic Potential. | Cureus | 2025 | https://conductscience.org/library/papers/41393541 | PubMed |
| 41392285 | SGLT2 inhibitors in cardiac amyloidosis: mechanistic insights and clinical perspectives-a narrative review. | Cardiovasc Diabetol Endocrinol Rep | 2025 | https://conductscience.org/library/papers/41392285 | PubMed |
| 41375659 | Metabolic Predictors of CAD: Focus on Cystine, Methionine, Proline, and Threonine Circulating Levels-Exploratory Pilot Study. | J Clin Med | 2025 | https://conductscience.org/library/papers/41375659 | PubMed |
| 41366613 | Dapagliflozin Reduces Ambulatory Arterial Stiffness Index in CKD Patients with and Without Diabetes Independently of Blood Pressure Control: Results from the GLUcose Transport and Renal PROtection in Chronic Kidney Disease (GLUTREPRO) Trial. | High Blood Press Cardiovasc Prev | 2026 | https://conductscience.org/library/papers/41366613 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| SLC24A3 | 57419 | PubTator's text mining | https://conductscience.org/library/genes/57419 | NCBI Gene |
| SLC9A1 | 6548 | PubTator's text mining | https://conductscience.org/library/genes/6548 | NCBI Gene |
| TLX2 | 3196 | PubTator's text mining | https://conductscience.org/library/genes/3196 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40366385
GET https://conductscience.org/api/papers/v1/40366385/references?page=2